| Participant Role | Details | Start Time | Minutes | Action |
|---|---|---|---|---|
| Application | Gene expression analysis of the bladder tumor microenvironment reveals a novel B cell signature in NMIBC patients after treatment with M. bovis BCG | 08:00 PM | 5 | View |
| Application | ASSOCIATION BETWEEN DISEASE INDICATION AND STEROID USE AND MINERALOCORTICOID-RELATED TOXICITY OF ABIRATERONE ACETATE IN PATIENTS WITH ADVANCED PROSTATE CANCER: A META-ANALYSIS OF RANDOMIZED CONTROL TRIALS | 08:05 PM | 5 | View |
| Application | Decisional Regret and Financial Toxicity among Patients with Benign Renal Masses | 08:10 PM | 5 | View |
| Application | SIGNIFICANT ANTI-ADENOVIRUS ANTIBODY RESPONSE POSITIVELY CORRELATES WITH EFFICACY IN PATIENTS TREATED WITH NADOFARAGENE FIRADENOVEC FOR HIGH-GRADE BCG-UNRESPONSIVE NMIBC | 08:15 PM | 5 | View |
| Application | Determining the impact of genomic classifier testing on patient-reported quality of life in men at high-risk of post-prostatectomy recurrence: results from G-MINOR randomized clinical trial | 08:20 PM | 5 | View |
| Application | OBESITY EXPLAINS SIGNIFICANT STATEWIDE VARIATION IN RENAL PARENCHYMAL TUMOR INCIDENCE IN THE UNITED STATES | 08:25 PM | 5 | View |
| Total: | 30 Minute(s) |
Young Urologic Oncologists (YUO) Program
Description
Day: 12/2/2020
Room: Zoom
Time: 8:00 PM - 8:30 PM